Mark Hasleton

Mark Hasleton Email and Phone Number

Acting Chief Executive Officer @ PROTA THERAPEUTICS PTY LTD
Israel
Mark Hasleton's Location
Israel, Israel
Mark Hasleton's Contact Details

Mark Hasleton personal email

About Mark Hasleton

I am passionate about all innovation in the Healthcare industry from pharmaceuticals and diagnostics to digital healthcare and medical devices.• With over 20 years of global biotech / device and pharma experience I have a track record of solving complex problems and delivering innovative solutions that improve outcomes for patients, healthcare providers and families.• Managed multiple Proof of Concept (POC) projects for new devices and drug, delivering results to rapidly reach a decision point on the adoption of new platforms for Teva.• Creating and delivering ideation processes that are constantly seeking the next big innovation. Ideapharma named Teva as one of the top ten most exciting innovators in biopharma for patient-centric approach in New Therapeutic Entities.• PhD in breast cancer research and post doc experience at the Institute for Cancer Research in the UK.• MBA from Imperial College.

Mark Hasleton's Current Company Details
PROTA THERAPEUTICS PTY LTD

Prota Therapeutics Pty Ltd

View
Acting Chief Executive Officer
Israel
Employees:
5
Mark Hasleton Work Experience Details
  • Prota Therapeutics Pty Ltd
    Acting Chief Executive Officer
    Prota Therapeutics Pty Ltd
    Israel
  • Sprim Global Investments
    Vp Clinical Trial Financing
    Sprim Global Investments Apr 2021 - Present
    Singapore
  • Cgrp Diagnostics / 428 Pharma
    Co- Founder
    Cgrp Diagnostics / 428 Pharma Jun 2018 - Present
    Israel
  • Teva Pharmaceuticals
    Senior Director, Global Nte Pipeline Manager At Teva Pharmaceuticals
    Teva Pharmaceuticals Oct 2011 - Mar 2018
  • Teva Pharmaceuticals
    Director Ex-Us Sourcing Global Branded Products
    Teva Pharmaceuticals Oct 2010 - 2012
    Actively seeking value add opportunities to grow Teva's branded pipeline. Focusing on UK and Scandinavia
  • Bristol Myers Squibb
    Eu Business Operations Manager
    Bristol Myers Squibb Aug 2007 - Oct 2010
  • Ml Laboratories
    Research Associate
    Ml Laboratories 2002 - 2005
  • Imperial Cancer Research Fund
    Phd Student
    Imperial Cancer Research Fund 1997 - 2001

Mark Hasleton Skills

Business Development Biotechnology Lifesciences Pharmaceutical Industry Molecular Oncology Clinical Development Oncology Clinical Trials Technology Transfer Immunology Molecular Biology Drug Discovery Biochemistry Cancer Regulatory Affairs Biopharmaceuticals R&d Cell Biology Neuroscience Clinical Research

Mark Hasleton Education Details

Frequently Asked Questions about Mark Hasleton

What company does Mark Hasleton work for?

Mark Hasleton works for Prota Therapeutics Pty Ltd

What is Mark Hasleton's role at the current company?

Mark Hasleton's current role is Acting Chief Executive Officer.

What is Mark Hasleton's email address?

Mark Hasleton's email address is ma****@****arm.com

What schools did Mark Hasleton attend?

Mark Hasleton attended Imperial College Business School, Imperial College London, Bar-Ilan University.

What skills is Mark Hasleton known for?

Mark Hasleton has skills like Business Development, Biotechnology, Lifesciences, Pharmaceutical Industry, Molecular Oncology, Clinical Development, Oncology, Clinical Trials, Technology Transfer, Immunology, Molecular Biology, Drug Discovery.

Not the Mark Hasleton you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.